Z5K-76034-57205
5 vaccinations
3 coded responses
32 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 294 / SC
- Registered
- 2021-02-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-06
Dose 1 — Pfizer-BioNTech
-
2021-02-27
Dose 2 — Pfizer-BioNTech
-
2021-02-28
Registered in v-safe
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-01
-
2021-03-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-03-27
- 2021-04-05
- 2021-04-10
- 2021-05-29
- 2021-08-28
-
2021-10-08
Dose 3 — Pfizer-BioNTech
-
2022-03-01
Survey response — 12 months, dose 2MedDRA: COVID-19, Dyspnoea, Fatigue, Feeling abnormal, Speech disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Since having Covid on January 8th and recovering from the worst of it in 2 weeks, I continue to have Shortness of breath, extreme fatigue, especially if I have worked or exercises in any way, fuzzy brain, trouble finding words, etc.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-08
Survey response — 6 months, dose 3MedDRA: Fatigue, Malaise, Memory impairment — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Post exertion malise Fatigue Memory blipsMedDRA releases: 2024-11 · check-in free text available
-
2022-05-24
Dose 4 — Pfizer-BioNTech
- 2022-06-02
- 2022-06-07
- 2022-06-14
- 2022-06-21
- 2022-06-28
- 2022-07-06
-
2022-08-23
Survey response — 3 months, dose 4MedDRA: Brain fog, Dyspnoea, Fatigue, Mental fatigue, Post-acute COVID-19 syndrome — Feeling: Good · Be unable to do your normal daily activitiesFree text: I think it was a relapse of the long Covid. Exhausted again physically and mentally, brain fog, some shortness of breath. It lasted for about a week.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-26
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-02
- 2022-10-03
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-10-31
- 2022-11-07
- 2022-12-26
- 2023-03-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-06 | Pfizer-BioNTech | |
| 2 | 2021-02-27 | Pfizer-BioNTech | |
| 3 | 2021-10-08 | Pfizer-BioNTech | No |
| 4 | 2022-05-24 | Pfizer-BioNTech | No |
| 5 | 2022-09-26 | Pfizer-BioNTech | Flu |
Free text
Release 11 — 12 months, dose 2
Symptoms: Since having Covid on January 8th and recovering from the worst of it in 2 weeks, I continue to have Shortness of breath, extreme fatigue, especially if I have worked or exercises in any way, fuzzy brain, trouble finding words, etc.
Release 11 — 6 months, dose 3
Symptoms: Post exertion malise Fatigue Memory blips
Release 12 — 3 months, dose 4
Symptoms: I think it was a relapse of the long Covid. Exhausted again physically and mentally, brain fog, some shortness of breath. It lasted for about a week.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Feeling abnormal | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Memory impairment | · | · | ✓ |
| SD | Mental fatigue | · | · | ✓ |
| SD | Post-acute COVID-19 syndrome | · | · | ✓ |
| SD | Speech disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release